Here is the latest stock price and chart of Sun Pharma. For more details, see the Sun Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
LIVE on April 23rd: Has Covid impacted India's long-term growth potential?
Live BSE Quotes | Apr 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)640.25 | Open (Rs) 652.00 | High (Rs) 657.70 | Low (Rs) 637.00 |
% Change-0.74 | Volume 729,977 | Value (Rs) 473,063,667 | 52-Week H/L 659.50 / 434.25 |
Live NSE Quotes | Apr 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)639.95 | Open (Rs) 650.70 | High (Rs) 658.00 | Low (Rs) 638.10 |
% Change-0.81 | Volume 11,295,290 | Value (Rs) 7,336,076,401 | 52-Week H/L 659.50 / 434.25 |
Change | |||||
---|---|---|---|---|---|
1 Day -0.74% | 1 Month 8.34% | 3 Months 11.34% | 1 Year 35.00% | 5 Years (CAGR)* -4.83% | 10 Years (CAGR)* 11.14% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 8.02 | P/E Ratio (x) 79.80 | Market Cap (Rs m) 1,540,923.61 | P/BV (x) 3.40 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
SUN PHARMA last traded price was down 0.7% to Rs 640.3 on the BSE. On the NSE, SUN PHARMA last traded price was down 0.8% to Rs 640.0. The total volume of shares traded was 12.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.1%. And the benchmark S&P BSE SENSEX was at 48,080.7 (up 0.8%).
Over the last 30 days, the SUN PHARMA share price is up 8.3%. And over the last one year, SUN PHARMA share price is up 35.2%.
What else is happening in the markets today? Dig in...
Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.
For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
In this video I tell you the three Nifty ETFs I think are the best.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More